Hanane has 13 years of experience in market access and value assessment of pharmaceutical products. Her work has focused on overseeing and developing global value dossiers, jurisdictional reimbursement dossiers, and payer value propositions, in addition to conducting primary research, literature reviews, data analysis and research dissemination. She has covered a range of therapeutic areas, including oncology, rheumatology, cardiovascular disease, endocrinology, infectious diseases, ophthalmology, and rare diseases. She was one of the lead investigators in the EVIDEM collaboration focused on multicriteria decision analysis. Hanane holds a PhD in Biochemistry from McGill University where she studied signal transduction pathways in breast cancer, and an MSc in Nutrition from Université de Montréal (research on glucose metabolism).